IDXXIdexx Laboratories
$518.01-21% 1Y
$518.01
$504.5952 weeks$766.68
The financials
Idexx Laboratories by the numbers
Idexx Laboratories (IDXX) reported revenue of $1.22B in Q2 2026 (quarter ended Jun 30, 2026), up 9.7% from the same quarter a year earlier. That came with a gross margin of 64% and net income of $338M (28% of revenue). For the full year FY2025, revenue was $4.30B (+10% year on year) and net income $1.06B. Its largest product in Q2 2026 was Vet Lab Consumables at $430M, 35% of the disclosed total, just ahead of Reference Laboratory Diagnostic And Consulting Services at 33%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.22B | $1.11B | +9.7% |
| Gross profit | $779M | $695M | +12% |
| Operating income | $426M | $373M | +14% |
| Net income | $338M | $294M | +15% |
| Diluted EPS | $4.27 | $3.63 | +18% |
| Product | Revenue | Share |
|---|---|---|
| Vet Lab Consumables | $430M | 35% |
| Reference Laboratory Diagnostic And Consulting Services | $407M | 33% |
| Rapid Assay Products | $102M | 8.4% |
| Veterinary Software Services And Diagnostic Imaging Systems | $96M | 7.9% |
| Recurring | $76M | 6.3% |
| CAG Diagnostic Capital Instruments | $47M | 3.9% |
| CAG Diagnostics Service And Accessories | $36M | 3.0% |
| Systems And Hardware | $20M | 1.6% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q2 2026Total $1.21B (+6.0%)
Systems And Hardware grew +18% year on yearCAG Diagnostic Capital Instruments -19% year on year
Segment Latestquarter on quarteryear on year
- Vet Lab Consumables$430.3M$430.3Mquarter on quarter +4.3%year on year +15%+4.3%+15%
- Reference Laboratory Diagnostic And Consulting Services$406.7M$406.7Mquarter on quarter +5.3%year on year +11%+5.3%+11%
- Rapid Assay Products$101.6M$101.6Mquarter on quarter +20%year on year +1.3%+20%+1.3%
- Veterinary Software Services And Diagnostic Imaging Systems$96.3M$96.3Mquarter on quarter +5.5%year on year +12%+5.5%+12%
- Recurring$76.3M$76.3Mquarter on quarter +3.8%year on year +11%+3.8%+11%
- CAG Diagnostic Capital Instruments$47.2M$47.2Mquarter on quarter +11%year on year -19%+11%-19%
- CAG Diagnostics Service And Accessories$36.1M$36.1Mquarter on quarter -1.5%year on year +3.2%-1.5%+3.2%
- Systems And Hardware$20.0M$20.0Mquarter on quarter +13%year on year +18%+13%+18%
On our screens:Stocks that buy back more than they dilute
Diagnostics & Research
The closest names by size in the same industry